Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1333-1340, July 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clewell, D. B.
Right arrow Articles by Hodes, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clewell, D. B.
Right arrow Articles by Hodes, M. E.

Fractionation of Spleen and Serum in Attempts to Isolate the Radiation-Leukemia Protection Factor1

Don B. Clewell2, J. Donald Hubbard, Pao-Lo Yu, Lily C. Yip and M. E. Hodes

Cancer Research and the Departments of Medicine, Biochemistry, Pathology, Psychiatry, and Medical Genetics, Indiana University Medical Center, Indianapolis, Indiana 46202

The leukemia induced in C57BL mice by X-irradiation can be prevented by injection of extracts of sheep spleen or serum. These materials have been fractionated by ammonium sulfate precipitation followed by chromatography on Sephadex G-200. Radiation-leukemia protection (RLP) activity precipitates partially between 0–40% and 40–60% saturation with ammonium sulfate. During chromatography on Sephadex, most of the leukemia protective activity appears to elute with the higher molecular weight proteins of sheep spleen but with the smaller proteins of sheep serum. Cohn fractions III, III-0, IV-1, and IV-4 from commercial sources have shown RLP activity on one or more tests. All the preparations tested were heterogeneous on polyacrylamide gel electropherograms. It is suggested that more than one polypeptide exhibits leukemia protection activity.

1 Supported in part by a contract with the United States Atomic Energy Commission, AT(11-1) 1391 and the Indiana Elks. Taken in part from a thesis submitted by Don B. Clewell to the Graduate School, Indiana University, in partial fulfillment of the requirements for the Ph.D. degree.

2 Supported by a training grant (TI CA 5066) from the National Cancer Institute. Present address: Department of Biology, University of California, San Diego, La Jolla, California.

Received 4/10/67. Accepted 2/11/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.